EXPLORE!

Market Authorization for Covovax as Heterlogous Booster Dose Recommended by Panel

  493 Views

PTI    13 January 2023

On Thursday, an expert panel of the central drug regulatory authority recommended market authorization for Serum Institute of India′s Covid vaccine Covovax as a heterologous booster dose for adults who have completed their primary vaccination schedule, including two doses of Covishield or Covaxin.

 

Recently, Dr. Prakash Kumar Singh, director, Serum Institute of India (SII), wrote a letter to the Drugs Controller General of India (DCGI) seeking approval for Covovax as a heterologous booster dose.

 

An official source revealed that on Wednesday, the subject expert committee (SEC) of the CDSCO discussed the issue and recommended the market authorization of the Covid vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.